United States · FDA National Drug Code directory

Amphetamine Extended-Release

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62542-025_3f9283a3-e922-36ca-e063-6394a90a409d
Product NDC: 62542-025
Form: TABLET, ORALLY DISINTEGRATING
Composition / generic term: Amphetamine Extended-Release
Labeler: Neos Therapeutics, LP
Marketing category: NDA AUTHORIZED GENERIC
Marketing start / end (source format): 20250901
Source listing expiry: 20261231

Source-listed ingredients

AMPHETAMINE — 15.7 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 BLISTER PACK in 1 CARTON (62542-025-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 62542-025-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →